Titan Pharmaceuticals (NASDAQ:TTNP) Share Price Crosses Above 200 Day Moving Average – Here’s What Happened

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $3.83 and traded as high as $4.34. Titan Pharmaceuticals shares last traded at $4.34, with a volume of 464 shares.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen assumed coverage on shares of Titan Pharmaceuticals in a research note on Tuesday, May 20th. They set a “sell” rating on the stock.

Titan Pharmaceuticals Trading Down 1.5%

The company has a market cap of $3.94 million, a P/E ratio of -0.94 and a beta of 1.30. The business’s 50 day simple moving average is $4.29 and its 200 day simple moving average is $3.83.

Titan Pharmaceuticals (NASDAQ:TTNP) last released its quarterly earnings data on Wednesday, May 14th. The specialty pharmaceutical company reported ($0.62) earnings per share (EPS) for the quarter.

About Titan Pharmaceuticals

Titan Pharmaceuticals, Inc, a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally. It develops products based on ProNeura, a proprietary long-term drug delivery platform. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; and Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder.